Skip to content
Comparison

Selank vs Phenibut

Selank and Phenibut are commonly compared for anxiety modulation with different dependence profiles. Selank is usually favored for lower dependence risk anxiolytic peptide pathway, while Phenibut is often preferred for strong acute anxiolysis with tolerance/withdrawal concerns. This head-to-head analysis focuses on mechanism, trial outcomes, dosing context, evidence quality, regulatory status, and practical decision points for safer YMYL decision-making.

4.3(112 ratings)

Quick Answer

For anxiety modulation with different dependence profiles, the better choice depends on your primary endpoint. Selank is stronger when the priority is sustainable anxiety-support strategy. Phenibut is stronger when the priority is short-term rescue-only situations under caution. Use evidence grade, dose intensity, access constraints, and tolerability profile to match therapy to the patient profile rather than choosing by hype alone.

Head-to-Head Comparison

CriteriaSelankPhenibut
Primary mechanismTuftsin-derived anxiolytic neuropeptide with GABAergic modulationGABA-B receptor active anxiolytic compound (non-peptide)
Strongest clinical signalAnxiety and stress-modulation signals without classic sedative burdenShort-term anxiolytic effects with dependence/tolerance risk
Typical dosing contextIntranasal divided dosing protocolsOral dosing varies; misuse risk increases with frequent use
AdministrationIntranasalOral
Evidence quality gradePreliminary-to-moderate evidence in regional studiesLimited formal modern trial base in Western practice
Regulatory statusNot FDA-approved in USUnapproved dietary-supplement gray-market use in many regions
Side-effect burdenGenerally well tolerated in short-term studiesWithdrawal and dependence concerns are major limitations
Cost/access contextModerate specialty pricingLow upfront cost; high risk-cost if misused
Best candidate profileAnxiety-dominant cognitive stress profilesNot preferred for chronic anxiety due to dependence liability
Main limitationLimited large international RCT datasetsTolerance and withdrawal can be clinically significant
Best use case in this comparisonsustainable anxiety-support strategyshort-term rescue-only situations under caution

When to Choose Each

Choose Selank

Best for sustainable anxiety-support strategy.

Choose Phenibut

Best for short-term rescue-only situations under caution.

Verdict

If the main goal is sustainable anxiety-support strategy, Selank is usually the better first-line choice. If the main goal is short-term rescue-only situations under caution, Phenibut is typically the better fit. Reassess outcomes at 8-16 weeks with objective metrics, then adjust only when response, safety, or adherence data justify it. In high-risk populations, physician-guided personalization matters more than any generic ranking.

References

  1. Selank — anxiolytic peptide with nootropic and immunomodulatory properties: a review (2008) — PubMed
  2. Effect of Selank on the main monoamine systems of the brain: a review (2009) — PubMed
  3. Selank modulates the expression of genes encoding pro- and anti-inflammatory cytokines (2014) — PubMed
  4. Comparative anxiolytic activity of Selank and tuftsin on behavioral parameters in rats (2002) — PubMed

Compare Telehealth Providers

Find the right provider for your peptide therapy needs

Hims & Hers

Most Popular
4.3

Starting at $199/mo

Hims & Hers is a leading telehealth platform offering physician-supervised GLP-1 weight loss programs including compounded semaglutide and tirzepatide. Board-certified providers, async or video consults, and medication shipped to your door.

✓Large, established platform with strong physician network
✓Compounded semaglutide available where branded shortages exist
✓Easy async consult — no video call required
✗Does not offer a wide range of peptides beyond GLP-1s
✗Pricing is on the higher end for GLP-1 programs

Henry Meds

Most Peptides
4.2

Starting at $249/mo

Henry Meds is a telehealth provider specializing in hormone optimization and peptide therapy. Beyond GLP-1 weight loss, Henry Meds offers testosterone replacement therapy, growth hormone peptides, and other advanced hormonal protocols managed by licensed physicians.

✓Broadest peptide therapy menu of any major telehealth provider
✓Growth hormone peptides (sermorelin, ipamorelin, CJC-1295) available
✓Repair peptides including BPC-157 and TB-500
✗Higher starting price due to comprehensive programs
✗More complex onboarding including lab work requirements

Ro Body

Best Value
4.1

Starting at $149/mo

Ro Body is a telehealth weight management program powered by GLP-1 medications. Ro connects patients with licensed providers who prescribe compounded semaglutide or branded GLP-1 therapies depending on eligibility, paired with behavioral coaching.

✓Competitive pricing starting at $149/mo
✓Dedicated health coach included in program
✓Strong clinical protocols with lab-work integration
✗Narrower peptide offering — GLP-1s only
✗Video consult required for initial visit

Calibrate

4.0

Starting at $199/mo

Calibrate is a metabolic health company offering a one-year GLP-1 program built around four pillars: food, sleep, exercise, and emotional health. Calibrate works with insurance to cover medication costs and provides extensive behavioral coaching alongside prescriptions.

✓Insurance navigation support for medication coverage
✓Evidence-based one-year program with structured milestones
✓Four-pillar lifestyle coaching (food, sleep, exercise, emotional health)
✗Annual program commitment required
✗Primarily focused on GLP-1s — no broader peptide therapy

Found

3.9

Starting at $129/mo

Found is a weight management telehealth platform that combines GLP-1 medications with behavioral coaching and a supportive community. Found emphasizes a whole-person approach, pairing pharmacological treatment with lifestyle intervention for sustainable results.

✓One of the more affordable monthly program fees
✓Strong community and peer support features
✓Certified health coaches with regular check-ins
✗Medication billed separately from program fee — total cost can be higher
✗Limited peptide variety beyond standard GLP-1s

Sponsored · We may earn a commission. Learn more · Updated February 2026

Frequently Asked Questions

Which has stronger evidence for anxiety modulation with different dependence profiles — Selank or Phenibut?
Selank is graded as preliminary-to-moderate evidence in regional studies evidence in this context, while Phenibut is graded as limited formal modern trial base in western practice. In practice, strength depends on whether you prioritize sustainable anxiety-support strategy or short-term rescue-only situations under caution. Favor the option with endpoint data closest to your primary goal, and avoid extrapolating beyond studied populations.
Can Selank and Phenibut be combined or sequenced?
Sometimes, but only with clinician oversight. A common framework is to start with one agent, track objective response for 8-16 weeks, then switch or sequence if outcomes plateau or tolerability is poor. Combination protocols may increase both cost and adverse-effect complexity, so they should be justified by clear endpoint-based rationale.
What should be monitored before and during treatment?
Baseline assessment should include diagnosis confirmation, comorbidity risk, and contraindications. During therapy, monitor target outcomes (symptoms, body composition, labs), adverse effects, and adherence burden. For endocrine/metabolic strategies, periodic glucose, lipids, organ function, and indication-specific labs help keep risk proportional to expected benefit.

Explore next

More comparisons